From: Contagion Live <edigest@contagionlive.com>
Sent: <Variable Day of week, Month day, 2020 Time AM or PM>
To: <Variable attendee email address>
Subject: Live Broadcast Invitation: Retooling Tetracyclines for 21st Century Challenges
No Images? Click here
|
|
|
This promotional program is sponsored by Paratek Pharmaceuticals, Inc and it is not eligible for continuing medical education credits.
|
|
|
|
Retooling Tetracyclines for 21st Century Challenges
Don’t miss this opportunity to learn more about the clinical and practical considerations for classic and emerging tetracycline-class antibiotics.
|
|
In this Live Broadcast, Retooling Tetracyclines for 21st Century Challenges, our expert faculty will:
|
|
|
Review the historical
background on tetracycline
discovery, emerging resistance,
mechanism of action, and their
spectrum of activity.
|
|
|
|
|
Compare pharmacokinetic and pharmacodynamic similarities and differences for tetracycline antibiotics.
|
|
|
|
|
Discuss the clinical data supporting tetracycline use for common bacterial infections including complicated intra-abdominal infections, skin and skin structure infections, and community acquired bacterial pneumonia.
|
|
|
|
|
Identify applications for tetracycline-class antibiotics after assessing risks and benefits given a patient case.
|
|
|
|
|
Kerry Laplante, PharmD, FCCP, FIDSA
Professor of Pharmacy University of Rhode Island, Kingston, RI
Adjunct Professor of Medicine Brown University, Providence, RI
Director of the Rhode Island Infectious Diseases Fellowship and Research Programs
|
|
|
Abhay Dhand, MD
Director, Transplant Infectious Diseases Westchester Medical Center, Valhalla, NY
Associate Professor of Medicine New York Medical College, Valhalla, NY
|
|
|
|
© 2020 Paratek Pharmaceuticals, Inc. All rights reserved.
PARATEK® and the hexagon logo are registered trademarks of
Paratek Pharmaceuticals, Inc.
US-NUA-0xxx 0x/20
|
|
|
|
|
Contagion® – an MJH Life Sciences® brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512
Preferences | Unsubscribe
|
|
|